Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
32
Number of overlapping holdings
23.5%
% of XBI's 136 holdings also in FTXH
64.0%
% of FTXH's 51 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
UNITED THERAPEUTICS CORP | 2.9% | 3.8% | 2.9% |
|
GILEAD SCIENCES INC | 2.9% | 4.4% | 2.9% |
|
AMGEN INC | 2.3% | 3.3% | 2.3% |
|
ABBVIE INC | 2.3% | 6.6% | 2.3% |
|
BIOGEN IDEC INC | 2.2% | 3.1% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to FTXH
|
NATERA INC | 3.1% |
|
INCYTE CORP | 2.6% |
|
ADVENTRX PHARMACEUTICALS INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.1% |
|
INSMED INC | 1.9% |
|
SAREPTA THERAPEUTICS INC | 1.9% |
|
ALNYLAM PHARMACEUTICALS INC | 1.8% |
|
CYTOKINETICS INC | 1.7% |
|
CRISPR THERAPEUTICS AG | 1.6% |
XBI Underweight Relative to FTXH
|
BRISTOL-MYERS SQUIBB CO | -8.8% |
|
JOHNSON & JOHNSON | -7.3% |
|
PFIZER INC | -6.7% |
|
MERCK & CO. INC. | -6.4% |
|
ABBVIE INC | -4.3% |
|
VIATRIS, INC. | -4.2% |
|
CARDINAL HEALTH INC | -4.1% |
|
ZOETIS INC | -3.7% |
 |
JAZZ PHARMACEUTICALS PLC | -3.5% |
|
ELI LILLY & CO | -3.0% |